Santos-Martínez N, Díaz L, Ortiz-Ortega VM, Ordaz-Rosado D, Prado-Garcia H, Avila E, Larrea F, and García-Becerra R.
Calcitriol induces estrogen receptor α expression through direct transcriptional regulation and epigenetic modifications in estrogen receptor-negative breast cancer cells.
American Journal of Cancer Research 11: 5951-5964
2021
García-Becerra R.; García S.; Mercado-Sánchez I.; Bahena L.; Alcaraz Y.; García-Revilla M.A.; Robles J.; Santos-Martínez N.; Ordaz-Rosado D.; Vazquez M.A.
Design of Fluorescent Coumarin-Hydroxamic Acid Derivatives as Inhibitors of HDACs: Synthesis, Anti-Proliferative Evaluation and Docking Studies
Molecules, Volume 25 Número 21 DOI: 10.3390/molecules25215134
2020
Segovia-Mendoza M.; García-Becerra R.; Ambrosio J.; Nava-Castro K.E.; Morales-Montor J.; Gómez de León C.T.
The chemical environmental pollutants BPA and BPS induce alterations of the proteomic profile of different phenotypes of human breast cancer cells: A proposed interactome
Environmental Research, Volume 191 DOI: 10.1016/j.envres.2020.109960
2020
Barrera, David; Camacho-Camacho, Carlos; Garcia-Becerra, Rocib; Larrea, Fernando; Martinez-Reza, Isela; Prado-Garcia, Heriberto; Rojas-Oviedo, Irma; Segovia-Mendoza, Mariana
An organotin indomethacin derivative inhibits cancer cell proliferation and synergizes the antiproliferative effects of lapatinib in breast cancer cells
American Journal Of Cancer Research, Volume 10 Número 10 Páginas 3358 a la 3369
2020
García-Quiroz J, García-Becerra R, Santos-Cuevas C, Ramírez-Nava GJ, Morales-Guadarrama G, Cárdenas-Ochoa N, Segovia-Mendoza M, Prado-Garcia H, Ordaz-Rosado D, Avila E, Olmos-Ortiz A, López-Cisneros S, Larrea F, Díaz L.
Synergistic Antitumorigenic Activity of Calcitriol with Curcumin or Resveratrol is Mediated by Angiogenesis Inhibition in Triple Negative Breast Cancer Xenografts
Cancers 11(11):E1739 F.I. 6.162
2019
García-Quiroz J, González-González MA, Díaz D, Ordaz-Rosado D, Segovia-Mendoza M, Prado-Garcia H, Larrea F, and García-Becerra R.
Astemizole, an inhibitor of ether-à-go-go-1 potassium channel, increases the activity of the tyrosine kinase inhibitor gefitinib in breast cancer cells.
Rev Invest Clin. Aceptado
2019
Martínez-Reza I, Díaz L, Barrera D, Segovia-Mendoza M, Pedraza-Sánchez S, Soca-Chafre G, Larrea F, García-Becerra R.
Calcitriol inhibits the proliferation of triple negative breast cancer cells through a mechanism involving the proinflammatory cytokines IL-1β and TNF-α.
Journal of Immunology Research. 2019:1-11
2019
Olmos-Ortiz A, García-Quiroz J, Halhali A, Avila E, Zaga-Clavellina V, Chavira-Ramírez R, García-Becerra R, Caldiño-Soto F, Larrea F, and Díaz L.
Negative correlation between testosterone and TNF-α in umbilical cord serum favors a weakened immune milieu in the human male fetoplacental unit.
J Steroid Biochem Mol Biol. 186:154-160
2019
Lira-Albarrán S, Durand M, Barrera D, Vega C, García-Becerra R, Díaz L, García-Quiroz J, Rangel C, Larrea F.
A single preovulatory administration of ulipristal acetate affects the decidualization process of the human endometrium during the receptive period of the menstrual cycle.
Mol Cell Endocrinol 15: 476:70-78
2018
Martinez-Archundia M, García-Vázquez JB, Colin-Astudillo B, Bello M, Prestegui-Martel B, Chavez A, Dueñas-González A, Fragoso-Vázquez MJ, Mendieta-Wejebe J, Abarca-Rojano E, Ordaz-Rosado D, García-Becerra R, Castillo-Bautista D, and Correa Basurto J.
Computational Study of the Binding Modes of Diverse DPN Analogues on Estrogen Receptors (ER) and the Biological Evaluation of a New Potential Antiestrogenic Ligand
Anticancer Agents Med Chem. 18(11):1508-1520
2018
Martínez-Reza I, Díaz L, and García-Becerra R.
Preclinical and clinical aspects of TNF-α and its receptors TNFR1 and TNFR2 in breast cancer.
J Biomed Sci 24(90): 1-8
2017
Escudero-Castellanos A, Ocampo-García BE, Ferro-Flores G, Isaac-Olivé K, Santos-Cuevas CL, Olmos-Ortiz A, García-Quiroz J, García-Becerra R, and Díaz L.
Preparation and in vitro evaluation of 177Lu-iPSMA-RGD as a new heterobivalent radiopharmaceutical.
J Radioanal Nucl Chem
2017
Segovia-Mendoza M, Díaz L, Prado-Garcia H, Reginato MJ, Larrea F, and García-Becerra R.
The addition of calcitriol or its synthetic analog EB1089 to lapatinib and neratinib treatment inhibits cell growth and promotes apoptosis in breast cancer cells.
Am J Cancer Res 7(7): 1486-1500
2017
García-Quiroz J, García-Becerra R, Lara-Sotelo G, Avila E, López S, Santos-Martínez N, Halhali A, Ordaz-Rosado D, Barrera D, Olmos-Ortiz A, Ibarra-Sánchez MJ, Esparza-López J, Larrea F, and Díaz L.
Chronic moderate ethanol intake differentially regulates vitamin D hydroxylases gene expression in kidneys and xenografted breast cancer cells in female mice.
J Steroid Biochem Mol Biol 173: 148-156
2017
García-Quiroz J, García-Becerra R, Santos-Martínez N, Avila E, Larrea F, and Díaz L.
Calcitriol stimulates gene expression of cathelicidin antimicrobial peptide in breast cancer cells with different phenotype.
J Biomed Sci 23(78): 1-7
2016
Silva-Ortiz AV, Bratoeff E, Ramírez-Apan MT, García-Becerra R, Ordaz-Rosado D, Noyola-Martínez N, Castillo-Bocanegra R, and Barrera D.
Synthesis and biological activity of two pregnane derivatives with a triazole or imidazole ring at C-21.
J Steroid Biochem Mol Biol 159: 8-18
2016
Medina-García V, Ocampo-García B, Ferro-Flores G, Santos-Cuevas CL, Aranda-Lara L, García-Becerra R, Ordaz-Rosado D, and Melendez-Alafort L.
A freeze-dried kit formulation for the preparation of Lys27(99mTc-EDDA/HYNIC)-Exendin(9-39)/99mTc-EDDA/HYNIC-Tyr3-Octreotide to detect benign and malignant insulinomas.
Nucl Med Biol 42: 911-916
2015
Segovia-Mendoza M, González-González ME, Barrera D, Díaz L, and García-Becerra R.
Efficacy and mechanism of action of the tyrosine kinase inhibitors gefitinib, lapatinib and neratinib in the treatment of HER2-positive breast cancer: preclinical and clinical evidence.
Am J Cancer Res 5(9): 2531-2561
2015
Segovia-Mendoza M, Díaz L, González-González ME, Martínez-Reza I, García-Quiroz J, Prado-Garcia H, Ibarra-Sánchez MJ, Esparza-López J, Larrea F, and García-Becerra R.
Calcitriol and its analogues enhance the antiproliferative activity of gefitinib in breast cancer cells.
J Steroid Biochem Mol Biol 148: 122-131
2015
Chávez B, Ramos L, García-Becerra R, and Vilchis F.
Hamster SRD5A3 lacks steroid 5α-reductase activity in vitro.
Steroids 94:41-50
2015
Lemini C, Jaimez R, Pozas R, Franco Y, Avila ME, Figueroa A, Medina M, Lemus AE, García-Becerra R, Ordaz-Rosado D, and Larrea F.
In vivo and in vitro estrogenic profile of 17ß-amino-1,3,5(10)estratrien-3-ol.
J Steroid Biochem Mol Biol 147: 40-47
2015
Pérez A, Santos Cuevas CL, Chairez I, Poznyak T, Ordaz-Rosado D, García-Becerra R, and Romero Piña ME.
Ozone Dosage Effect on C6 Cell Growth: in Vitro and in Vivo Tests.
Anticancer Agents Med Chem. 15(9): 1190-6
2015
